V-Card | Print | PDF | Email

Kevin B. Espinola
Partner

Contact

Irvine
(T) +1.949.553.7509
(F) +1.949.553.7539
Silicon Valley
(T) +1.650.687.4181
(F) +1.650.739.3900

Education

  • University of Notre Dame (J.D. magna cum laude 1997); University of California, Irvine (B.A. 1993)

Bar Admissions

  • California
View All Experience

Celgene to buy Gloucester Pharmaceuticals for $640 million to bolster its anticancer drug pipeline

The following represents experience prior to joining Jones Day.

Public Company Mergers
  • Amgen Inc., in connection with its acquisition of Immunex Corporation ($16 billion)
  • Amgen Inc., in connection with its acquisition of Tularik, Inc. ($1.3 billion)
  • Axon Instruments, Inc., in connection with its sale to Molecular Devices Corporation ($140 million)
  • Axonyx, Inc., in connection with its sale to TorreyPines Therapeutics, Inc. ($80 million)
  • CIMA Labs Inc., in its terminated merger-of-equals transaction with aaiPharma Inc. ($900 million, combined value)
  • CIMA Labs Inc., in connection with the sale of the company to Cephalon, Inc. ($515 million)
  • FileNet Corporation, in connection with its sale to IBM ($1.6 billion)
  • First Consulting Group, in connection with its sale to Computer Sciences Corporation ($365 million)
  • Harrah’s Entertainment, Inc., in connection with its acquisition of Caesars Entertainment, Inc. ($9.44 billion)
  • Controlling stockholders of Hydril Corporation, in connection with the sale of the company to Tenaris S.A. ($2.16 billion)
  • ICOS Corporation, in connection with the sale of the company to Eli Lilly & Company ($2.3 billion)
  • InSight Health Services Corp., in connection with the sale of the company to J.W. Childs Associates, L.P. and The Halifax Group, L.L.C. ($450 million) (represented special committee and the company)
  • Interpore International, Inc., in connection with its sale to Biomet, Inc. ($280 million)
  • IsoTis Inc., in connection with the sale of the company to Integra Life Sciences Holding Corporation ($51 million)
  • Medicis Pharmaceutical Corporation, in connections with its terminated acquisition of Inamed Corporation ($2.8 billion)
  • Medicis Pharmaceutical Corporation, in connections with the successful defense against hostile bid made by Mentor Corporation
  • Micro Therapeutics, Inc, in connection with the sale of the company to its controlling stockholder, ev3 Inc. (represented special committee)
  • Ortel Corporation, in connection its acquisition by Lucent Technologies Inc. ($2.95 billion)
  • PIMCO Advisors, L.P., in connection with its acquisition of Oppenheimer Capital ($265 million)
  • The Sands Regent, in connection with the sale of the company to Herbst Gaming, Inc. ($148 million)
  • Tuboscope, Inc., in connection with its merger-of-equals with Varco International, Inc. ($1.8 billion, combined value)
  • Varco International, Inc, in connection with its merger-of-equals with National-Oilwell, Inc. ($5 billion, combined value)
  • Watson Pharmaceutical, Inc. in connection with its acquisition of Andrx Corporation ($1.9 billion)
Private Mergers
  • Advantage Sales & Marketing, LLC, in connection with its recapitalization and acquisition of a majority interest by Allied Capital Corporation
  • Ambassadors International, Inc., in connection with its acquisition of Bellingham Marine Industries, Inc. from Nishida Tekko Corporation
  • Ambassadors International, Inc., in connection with its acquisition of Newport Harbor Shipyard II, Inc.
  • Ambassadors International, Inc., in connection with its acquisition of BellPort Group, Inc. (represented special committee and company)
  • Ambassadors International, Inc., in connection with its acquisition of BellJa Holding Company, Inc.
  • Complete Production Services, in connection with its acquisition of Pumpco Services, Inc.
  • Harrah’s Entertainment, Inc., in connection with its acquisitions of Horseshoe Gaming Holding Corp.
  • Innovent Systems, Inc., in connection with the sale of the company to Broadcom Corporat


Experience Highlights

Areas of Focus

Kevin Espinola